Journal of Cancer Research and Therapeutics Close
 

Figure 3: Cell viability of DU145 and human foreskin fibroblasts cells after 48-h treatment with doxorubicin; 0.05 μM and/or zinc oxide nanofluid; 0.95 μg/ml either alone or in combination, in the absence or presence of ultraviolet A. *P < 0.05 versus combination-treated human foreskin fibroblasts cells in the presence of ultraviolet A, **P < 0.05 versus doxorubicin-alone treated DU145 cells

Figure 3: Cell viability of DU145 and human foreskin fibroblasts cells after 48-h treatment with doxorubicin; 0.05 μM and/or zinc oxide nanofluid; 0.95 μg/ml either alone or in combination, in the absence or presence of ultraviolet A. *<i>P</i> < 0.05 versus combination-treated human foreskin fibroblasts cells in the presence of ultraviolet A, **<i>P</i> < 0.05 versus doxorubicin-alone treated DU145 cells